Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -8.88 % |
3 Month Return | -11.88 % |
1 Year Return | + 39.68 % |
Market Stats | |
Previous Close | ₹54.67 |
Open | ₹57.50 |
Volume | 324.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹24.99Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹24.99 Cr |
P/B Ratio | 1.06 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 5.73 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹24.99 Cr | 104.25% | 0.53 | NA | NA | |
NA | ₹488.86 Cr | -6.78% | 0.60 | ₹29 Cr | ₹182 Cr | |
NA | ₹381.52 Cr | 84.76% | 0.55 | -₹20 Cr | ₹79 Cr | |
NA | ₹15.98 Cr | -5.62% | 0.50 | -₹2 Cr | ₹35 Cr | |
NA | ₹4,497.06 Cr | 78.58% | 0.53 | ₹96 Cr | ₹1,690 Cr |
Organisation | Colinz Laboratories Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Colinz Laboratories Ltd
Despite an 8.04% YoY decrease in revenue, Colinz Laboratories reported a 13.2% YoY increase in profit for Q1. Operating income and EPS also showed positive growth. The company has provided strong returns to investors over various periods.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Colinz Labs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 34.00% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 80.7% return, outperforming this stock by 41.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 66.00% of holdings in Jun 2024 quarter
Price Dip
In the last 3 months, Colinz Labs stock has moved down by -11.9%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 66% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 34% | 0.00 | |
Others | 0% | 0.00 |
Colinz Laboratories Ltd’s net profit jumped 16.67% since last year same period to ₹0.14Cr in the Q1 2024-2025. On a quarterly growth basis, Colinz Laboratories Ltd has generated 0% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Colinz Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Colinz Laboratories Ltd (531210) share price today is ₹54.4
Colinz Laboratories Ltd is not listed on NSE
Colinz Laboratories Ltd is listed on BSE
Today’s traded volume of Colinz Laboratories Ltd(531210) is 324.00.
Today’s market capitalisation of Colinz Laboratories Ltd(531210) is ₹24.99Cr.
Colinz Laboratories Ltd(531210 | Price |
---|---|
52 Week High | ₹84.4 |
52 Week Low | ₹35.2 |
Colinz Laboratories Ltd(531210) share price is ₹54.4. It is down -35.55% from its 52 Week High price of ₹84.4
Colinz Laboratories Ltd(531210) share price is ₹54.4. It is up 54.55% from its 52 Week Low price of ₹35.2
Colinz Laboratories Ltd(531210 | Returns |
---|---|
1 Day Returns | -0.27% |
1 Month Returns | -8.88% |
3 Month Returns | -11.88% |
1 Year Returns | 39.68% |